How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Neil Armstrong never actually said, "one small step for man, one giant leap for mankind." Well, not exactly, anyway. Speaking to the press in the days after the Apollo 11 spacecraft landed on the moon ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

Neil Alden Armstrong was born on Aug. 5, 1930, in Ohio. A naval pilot from 1949 to 1952, Armstrong flew 78 missions in Korea. After leaving active duty, he enrolled at Purdue University and earned a ...

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...